top of page

Low Cost, Highly Accurate, Simple to Use
Testing for All

Domus Diagnostics is working to combine cutting-edge custom chemistry with simple manufacturing technology in order to bring low-cost, high accuracy tests for infectious diseases everywhere they're needed.

​

Domus technology has disruptive potential across the continuum of care.

Proprietary* RT-LAMP one-step, one-temperature technology allows for high performance, low-cost solutions everywhere you find diagnostic tests

device-jan23-1C-transparent.png

At Home

Disposable, no-electricity home-resulting test

Clinics

Low-cost, no-service Desktop instrument

central lab-3.png

Central Laboratories

Lab-developed one-step tests; dedicated assays for established analyzer platforms

Domus tests will be among the first to meet the standards required for broad adoption in every global market.

affordable-wh.png

Low Cost

Novel chemistry and simple manufacturing allow for ultra low-cost solutions for at-home, point-of-care, and central laboratory testing

simple-steps-wh.png

Simple

Intuitive and easy to use, across languages,

education levels, and disabilities

accurate-wh-2.png

Accurate

As accurate as a

laboratory PCR test:

>95% sensitivity and

100% specificity*

rapid-wh.png

Rapid

Results in 30 minutes or less

mountains-blue.jpg

The National Institutes of Health (NIH) Rapid Acceleration of Diagnostics (RADx®) Tech program awards Domus a multi-million dollar grant.

The RADx Coordination Center at CIMIT, on behalf of the National Institute of Biomedical Imaging and Bioengineering (NIBIB) of the National Institutes of Health (NIH), selected Domus Diagnostics earlier this year from among hundreds of applicants to participate in their High-Performance COVID-19 Rapid Tests Fast-Track Program, to accelerate the development of their ultra-low-cost  nucleic acid at-home test.

bottom of page